MTM Laboratories has developed a proprietary technological platform that has identified a novel biomarker that serves for the early detection of cervical cancer.
Global Cancer Consortium
Anavex Receives Approval to Commence Phase I Clinical Trial in Alzheimer’s Disease
Anavex Life Sciences recently announced that its clinical trial application for ANAVEX 2-73, the company’s lead compound for Alzheimer’s disease, has been approved by the German regulatory health authority.
Photocure Develops a Non-surgical Treatment For HPV
A new non-surgical, tissue-preserving therapeutic procedure is being developed to more effectively remove HPV infection and treat precursors of cervical cancer.
Neo Matrix Can Detect Breast Cancer Years Before Tumor Build-Up
Neo Matrix is a medical devices company that has developed a novel diagnostic test to determine breast cancer risk. The company’s test uses breast fluid to analyze the presence of normal, pre-malignant […]
RealBio Technology Transforms Research & Pharmaceutical Testing
RealBio’s technology allows cells grown in a laboratory setting to develop as they would in a normal human body.
Molecular Diagnostics and the Changing Landscape: Considerations and Implications
Wednesday, March 23 – Thursday, March 24, 2011 Washington, DC Metro Area The Liaison Capitol Hill 415 New Jersey Avenue, NW Washington, DC 20001 Molecular Diagnostics And the Changing Landscape is an […]
Global In Vitro Diagnostic Market Analysis
A new market research report on the In Vitro Diagnostic market is now available in the reportlinker.com catalogue.
Colon Cancer Screening made Simple
Women should be aware that they have several options for colon cancer screening, and not only the often-dreaded colonoscopy, according to a new report from the American College of Obstetricians and Gynecologists.
